TNPH Stock Overview
Tian'an Pharmaceutical Co., Ltd. develops, manufactures, and sells traditional Chinese herbal medicines, including pallets, hard capsules, and soft ointments for the treatment and prevention of diseases in China.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Tian'an Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0066 |
| 52 Week High | US$0.025 |
| 52 Week Low | US$0.0028 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -34.00% |
| 3 Year Change | -88.21% |
| 5 Year Change | -89.02% |
| Change since IPO | -99.31% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| TNPH | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | -2.2% | -0.9% |
| 1Y | -34.0% | 13.8% | 25.0% |
Return vs Industry: TNPH underperformed the US Pharmaceuticals industry which returned 23.6% over the past year.
Return vs Market: TNPH underperformed the US Market which returned 30.4% over the past year.
Price Volatility
| TNPH volatility | |
|---|---|
| TNPH Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: TNPH has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine TNPH's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | n/a | Jianjun Weng | n/a |
Tian'an Pharmaceutical Co., Ltd. develops, manufactures, and sells traditional Chinese herbal medicines, including pallets, hard capsules, and soft ointments for the treatment and prevention of diseases in China. It also engages in the research and development of biology goods and health care products. The company’s pharmaceutical and nutraceutical products include Compound Ginseng capsule, a Chinese medicine preparation that is used to cure and treat prostate gland proliferation; Nizhuanle Yin granule, a Chinese medicine preparation that treats the decomposition or inflammation of the stomach's mucous membrane; and Tianan soft capsule, which is used to adjust high amounts of fat in the blood stream, improve blood vessel ventilation, and soften blood vessels.
Tian'an Pharmaceutical Co., Ltd. Fundamentals Summary
| TNPH fundamental statistics | |
|---|---|
| Market cap | US$539.39k |
| Earnings (TTM) | US$3.14m |
| Revenue (TTM) | US$10.65m |
0.0x
P/E Ratio0.0x
P/S RatioIs TNPH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TNPH income statement (TTM) | |
|---|---|
| Revenue | US$10.65m |
| Cost of Revenue | US$3.35m |
| Gross Profit | US$7.30m |
| Other Expenses | US$4.16m |
| Earnings | US$3.14m |
Last Reported Earnings
Dec 31, 2007
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did TNPH perform over the long term?
See historical performance and comparison